Concepedia

Kevin C. Ludwig

KC

Statistics

Publications

7

Citations

532

H-Index

7

Active since

2017

Affiliations

University of Bonn(Current)

German Center for Infection Research

University Hospital Bonn

Northeastern University

NovoBiotic Pharmaceuticals

Kevin C. Ludwig is an author at University of Bonn specializing in life sciences, microbiology, and bacterial cell wall biosynthesis.

ORCID

Publications per year

2017–2023

7

Publications

7

Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids

Fabian Grein, Anna Müller, Katharina M. Scherer et al. · Nature Communications · 2020 · 237 citations · Full text

, , +17

An antibiotic from an uncultured bacterium binds to an immutable target

Rhythm Shukla, Aaron J. Peoples, Kevin C. Ludwig et al. · Cell · 2023 · 136 citations · Full text

, , +17

The Lasso Peptide Siamycin-I Targets Lipid II at the Gram-Positive Cell Surface

Stephanie Tan, Kevin C. Ludwig, Anna Müller et al. · ACS Chemical Biology · 2019 · 60 citations

, , +16

Biosynthesis and Mechanism of Action of the Cell Wall Targeting Antibiotic Hypeptin

Daniel A. Wirtz, Kevin C. Ludwig, Melina Arts et al. · Angewandte Chemie International Edition · 2021 · 39 citations · Full text

, , +15

Steroids originating from bacterial bile acid degradation affect Caenorhabditis elegans and indicate potential risks for the fauna of manured soils

Martha N. Mendelski, Ramona Dölling, Franziska Maria Feller et al. · Scientific Reports · 2019 · 26 citations · Full text

, , +12

1–5 of 7